{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:28:21Z","timestamp":1746332901548},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hashimoto\u2019s disease has reportedly been associated with stroke; however, cerebrovascular morphology and clinical course remain poorly documented. The present study aimed to determine the angiographic features and clinical outcomes of intracranial arterial stenosis (IAS) associated with Hashimoto\u2019s disease in a retrospective cohort.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Overall, 107 adult patients with IAS were screened for anti-thyroid antibodies; of these, 26 patients tested positive. The 42 affected hemispheres were classified into subgroups according to the steno-occlusion site and the development of abnormal collateral (moyamoya) vessels. These subgroups were dichotomized into moyamoya vessels positive (MM type) and negative (non-MM type). The initial presentation, IAS progression, and vascular events during the follow-up period were compared.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The following sites of stenosis were identified: the bifurcation of the internal carotid artery in 11 (26.2%), M1 or A1 in 29 (69.0%), and more distal (M2-M4\/A2-A4) in 2 (4.8%) hemispheres. Further, 17 hemispheres were categorized into the MM type and 25 were classified into the non-MM type. During the follow-up period (mean 2.5\u2009years), IAS progression was identified in 8 (32%) hemispheres of the non-MM type and 0 (0%) hemispheres of the MM type (<jats:italic>p<\/jats:italic>\u2009=\u20090.041). Ischemic attacks occurred in 5 (20.0%) hemispheres of the non-MM type (4.6%\/year) and 0 hemispheres of the MM type (<jats:italic>p<\/jats:italic>\u2009=\u20090.08). Further, 4 (23.5%) hemispheres of the MM type experienced intracerebral hemorrhage, whereas none of the non-MM type hemorrhaged (<jats:italic>p<\/jats:italic>\u2009=\u20090.012).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Hashimoto\u2019s disease-associated IAS exhibits various angiographic morphologies, resulting in different clinical presentations. Screening for anti-thyroid antibodies and careful management based on vascular morphology appears important in adults with IAS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01923-w","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T12:02:53Z","timestamp":1600084973000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intracranial arterial stenosis associated with Hashimoto\u2019s disease: angiographic features and clinical outcomes"],"prefix":"10.1186","volume":"20","author":[{"given":"Eika","family":"Hamano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisae","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Satow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun C.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"1923_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13:391\u20137.","journal-title":"Autoimmun Rev"},{"key":"1923_CR2","doi-asserted-by":"publisher","first-page":"979167","DOI":"10.1155\/2015\/979167","volume":"2015","author":"A Pyzik","year":"2015","unstructured":"Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roli\u0144ski J. Immune disorders in Hashimoto\u2019s thyroiditis: what do we know so far? J Immunol Res. 2015;2015:979167.","journal-title":"J Immunol Res"},{"key":"1923_CR3","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.3171\/2015.8.JNS141140a","volume":"123","author":"JB Chen","year":"2015","unstructured":"Chen JB, Lei D, He M, Sun H, Liu YZH. Clinical features and disease progression in moyamoya disease patients with graves disease. J Neurosurg. 2015;123:1608.","journal-title":"J Neurosurg"},{"key":"1923_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1212\/WNL.0000000000000377","volume":"82","author":"A Karch","year":"2014","unstructured":"Karch A, Thomas SL. Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study. Neurology. 2014;82:1643\u201352.","journal-title":"Neurology."},{"key":"1923_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","volume":"41","author":"SJ Kim","year":"2010","unstructured":"Kim SJ, Heo KG, Shin HY, Bang OY, Kim G-M, Chung C-S. Association of Thyroid Autoantibodies with Moyamoya-Type Cerebrovascular Disease a Prospective Study. Stroke. 2010;41:173\u20136.","journal-title":"Stroke."},{"issue":"3","key":"1923_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One. 2012;7(3):1\u20139.","journal-title":"PLoS One"},{"key":"1923_CR7","first-page":"1","volume":"14","author":"R Tashiro","year":"2019","unstructured":"Tashiro R, Niizuma K, Khor SS, Tokunaga K, Fujimura M, Sakata H, et al. Identification of HLA-DRB1\u221704:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study. PLoS One. 2019;14:1\u201312.","journal-title":"PLoS One"},{"key":"1923_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.wneu.2016.04.122","volume":"92","author":"NH Shah","year":"2016","unstructured":"Shah NH, Khandelwal P, Gordon-Perue G, Shah AH, Barbarite E, Ortiz G, et al. Acute thyrotoxicosis of graves disease associated with Moyamoya vasculopathy and stroke in Latin American women: a case series and review of the literature. World Neurosurg. 2016;92:95\u2013107.","journal-title":"World Neurosurg"},{"key":"1923_CR9","volume-title":"Guidelines for the diagnosis of chronic thyroiditis","author":"Japan thyroid association","year":"2010","unstructured":"Japan thyroid association. Guidelines for the diagnosis of chronic thyroiditis. 2010. http:\/\/www.japanthyroid.jp\/doctor\/guideline\/englis. Accessed 22 May 2020."},{"key":"1923_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3171\/2016.11.JNS161650","volume":"128","author":"T Funaki","year":"2018","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan adult Moyamoya trial. J Neurosurg. 2018;128:777\u201384.","journal-title":"J Neurosurg"},{"key":"1923_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/2017.9.JNS17576","volume":"130","author":"T Funaki","year":"2019","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan adult Moyamoya trial. J Neurosurg. 2019;130:525\u201330.","journal-title":"J Neurosurg"},{"key":"1923_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/2018.10.JNS181139","volume":"132","author":"T Funaki","year":"2020","unstructured":"Funaki T, Takahashi JC, Houkin K, Kuroda S, Fujimura M, Tomata Y, et al. Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan adult Moyamoya trial. J Neurosurg. 2020;132:408\u201314.","journal-title":"J Neurosurg"},{"key":"1923_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DSA McLeod","year":"2012","unstructured":"McLeod DSA, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42:252\u201365.","journal-title":"Endocrine."},{"key":"1923_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3904\/kjim.2003.18.4.244","volume":"18","author":"MC Lee","year":"2003","unstructured":"Lee MC, Lee YS, Ryu HS, Lee WS, Park WK, Chang TW. Systemic lupus erythematosus associated with familial moyamoya disease. Korean J Intern Med. 2003;18:244\u20137.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"1923_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/03009749709065707","volume":"26","author":"Y Matsuki","year":"1997","unstructured":"Matsuki Y, Kawakami M, Ishizuka T, Kawatuchi Y, Hidaka T, Suzuki K, Nakamura H. SLE and Sjogren s syndrome associated with unilateral Moyamoya vessels in cerebral arteries. Scand J Rheumatol. 1997;26(5):392\u20134.","journal-title":"Scand J Rheumatol"},{"key":"1923_CR16","first-page":"592","volume":"38","author":"S Nagahiro","year":"1996","unstructured":"Nagahiro S, Mantani A, Yamada K, Ushio Y. Multiple cerebral arterial occlusions in a young patient with Sj\u00f6gren\u2019s syndrome: case report. Neurosurgery. 1996;38:592\u20135.","journal-title":"Neurosurgery."},{"key":"1923_CR17","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.022","volume":"23","author":"H Sakata","year":"2014","unstructured":"Sakata H, Fujimura M, Sato K, Shimizu H, Tominaga T. Efficacy of extracranial-intracranial bypass for progressive middle cerebral artery occlusion associated with active Sj\u00f6gren\u2019s syndrome: case report. J Stroke Cerebrovasc Dis. 2014;23:e399\u2013402.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1923_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Dana Flanders W, Harry Hannon W, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1923_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NRGN. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223\u201343.","journal-title":"Clin Immunol Immunopathol"},{"key":"1923_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2176\/nmc.oa.2014-0360","volume":"55","author":"T Funaki","year":"2015","unstructured":"Funaki T, Fushimi Y, Takahashi JC, Takagi Y, Araki Y, Yoshida K, et al. Visualization of periventricular collaterals in moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: Preliminary experience. Neurol Med Chir (Tokyo). 2015;55:204\u20139.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1923_CR21","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3171\/2015.6.JNS15845","volume":"124","author":"T Funaki","year":"2016","unstructured":"Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, et al. Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg. 2016;124:1766\u201372.","journal-title":"J Neurosurg"},{"key":"1923_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.STR.0000047120.67507.0D","volume":"34","author":"M Morioka","year":"2003","unstructured":"Morioka M, Hamada JI, Kawano T, Todaka T, Yano S, Kai Y, et al. Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke. 2003;34:90\u20135.","journal-title":"Stroke."},{"key":"1923_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/STROKEAHA.110.608471","volume":"42","author":"H Li","year":"2011","unstructured":"Li H, Zhang Z-S, Dong Z-N, Ma M-J, Yang W-Z, Han C, et al. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with Moyamoya disease a case-control study. Stroke. 2011;42:1138\u20139.","journal-title":"Stroke."},{"key":"1923_CR24","first-page":"1541","volume":"25","author":"U Utku","year":"2004","unstructured":"Utku U, Asil T, \u00c7elik Y, Tucer D. Reversible MR angiographic findings in a patient with autoimmune graves disease. Am J Neuroradiol. 2004;25:1541\u20133.","journal-title":"Am J Neuroradiol"},{"key":"1923_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132:270\u20138.","journal-title":"Ann Intern Med"},{"key":"1923_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","volume":"148","author":"N Ochs","year":"2008","unstructured":"Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832\u201345.","journal-title":"Ann Intern Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01923-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01923-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:18:42Z","timestamp":1631575122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01923-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01923-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the research committee of National Cerebral and Cardiovascular Center, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Because no information that would allow identification of the patient was collected, individual patient consent was not required from patients. The opportunity to opt out of the study was always available to the research participants. This retrospective study was approved by the Ethics Committee of the National Cerebral and Cardiovascular Center (IRB approval no. M30\u2013013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}